Related Experiment Videos
[Lipoprotein (a) in liver diseases. Correlation between low levels and liver function]
P Selvais1, J Henrion, M Schapira
1Service de Médecine interne, Hôpital de Jolimont, Haine-Saint-Paul, Belgique.
Presse Medicale (Paris, France : 1983)
|February 25, 1995
Summary
Patients with liver disease exhibit lower serum lipoprotein(a) (Lp(a)) levels. This reduction is linked to the liver
Area of Science:
- Cardiovascular Science
- Hepatology
- Lipid Metabolism
Context:
- Lipoprotein(a) (Lp(a)) is an established risk factor for atherosclerosis.
- Liver function plays a crucial role in lipoprotein metabolism.
- Investigating the liver's influence on Lp(a) levels is vital for understanding cardiovascular risk in liver disease patients.
Purpose:
- To analyze the relationship between liver function and serum lipoprotein(a) (Lp(a)) levels.
- To compare Lp(a) levels in patients with and without liver disease.
- To determine if liver disease severity or cause (including alcohol intake) affects Lp(a) levels.
Summary:
- Patients with liver disease demonstrated significantly lower serum Lp(a) levels compared to controls.
- Lp(a) levels correlated negatively with liver disease severity (Child-Turcotte classification) and liver function tests, particularly those reflecting microsomal function and synthetic capacity (e.g., albumin, coagulation factors, apolipoprotein A-II).
- No significant difference in Lp(a) levels was observed between liver disease patients with and without chronic alcohol consumption.
Impact:
- Establishes a clear link between impaired liver function and reduced Lp(a) levels.
- Suggests that low Lp(a) in liver disease is a consequence of reduced hepatic synthesis, not a specific etiology like alcohol.
- Provides insights into cardiovascular risk stratification in patients with chronic liver conditions.